Journals / Uluslararası Hematoloji-Onkoloji Dergisi / 2015 / Cilt: 25 - Sayı: 1

65 Yaş ve Üzeri Kadınların Meme Kanseri Risk Düzeyleri ve Meme Kanserine Yönelik Farkındalıkları

The Risk Level of Breast Cancer and Breast Cancer Awareness Among the Turkish Women Aged 65 Years and Older

Pages
60–69
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It was found out that 1.6% of the women were under high risk while 2.7% of them were under very high risk for breast cancer.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:This study was conducted in order to determine risk level of breast cancer and breast cancer awareness among the women aged ≥ 65 years.
📊
Key Findings & Data:The sample of the study was composed of 445 women aged over ≥ 65 years.
💡
Conclusion & Impact:It was found out that 1.6% of the women were under high risk while 2.7% of them were under very high risk for breast cancer.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

This study was conducted in order to determine risk level of breast cancer and breast cancer awareness among the women aged &#8805; 65 years. The sample of the study was composed of 445 women aged over &#8805; 65 years. The data were gathered with Breast Cancer Risk Assessment Tool and Champion’s Health Belief Model Scale for breast cancer (HBMS) and were evaluated with percentages and Kruskal Wallis test. It was found out that 1.6% of the women were under high risk while 2.7% of them were under very high risk for breast cancer. Breast cancer risk for those with personal breast cancer history was very high (mean risk score (MRS): 549.58 ± 48.26) and breast cancer risk level of the women whose mothers and sisters had breast cancer history was high (MRS: 328.46 ± 107.02). It was noted in the study that as women’s breast cancer risk level went up so did their mean HBMS scores for susceptibility and health motivation (p<0.05). Women who had personal breast cancer history, whose family members had breast cancer history, whose menarche ages were &#8804; 11 years, who gave the first birth after the age of 30 had higher MRS as compared with the other women. Those who were susceptible to breast cancer and whose health motivation was high showed higher risk for breast cancer.

Özet

Bu çalışma, 65 yaş ve üzeri kadınların meme kanseri risk düzeylerini ve meme kanserine yönelik farkındalıklarını belirlemek amacıyla yapılmıştır. Araştırmanın örneklemini 65 yaş ve üzeri 445 kadın oluşturmuştur. Veriler, Meme Kanseri Risk Düzeyini Belirleme Formu, Champion’un Meme Kanserine İlişkin Sağlık İnanç Modeli Ölçeği (SİMÖ) kullanılarak toplanmış ve yüzdelik oranlar, aritmetik ortalama, standart sapma ve Kruskal Walls testi ile değerlendirilmiştir. Çalışmada kadınların meme kanseri açısından % 1.6’sı yüksek ve % 2.7’si ise çok yüksek risklidir. Ayrıca kişisel meme kanseri olan kadınların meme kanseri risk düzeyi çok yüksek (ORP: 549.58 ± 48.26), anne ve kız kardeşinde meme kanseri öyküsü olan kadınların (ORP: 328.46 ± 107.02) ise meme kanseri risk düzeyi yüksek bulunmuştur. Kadınların meme kanseri risk düzeyi arttıkça SİMÖ duyarlılık algısı ve sağlık motivasyonu puan ortalamalarının da arttığı tespit edilmiştir (p< 0.05). Çalışmada kişisel meme kanseri öyküsü olan, aile hikayesinde meme kanseri olan, menarş yaşı 11 ve altı olan ve ilk doğumunu 30 yaş sonrası yapan kadınların meme kanseri açısından ORP’ı diğer kadınlara göre daha yüksektir. Ayrıca çalışmada meme kanserine karşı duyarlı olan ve sağlık motivasyonları yüksek kadınların meme kanseri risk düzeyi yüksek olan kadınlar oldukları tespit edilmiştir.

🔖

Cite This Article

DUMAN, N. B., YILMAZEL, G., PINAR, G., BÜYÜKGÖNENÇ, L. A. (2015). 65 Yaş ve Üzeri Kadınların Meme Kanseri Risk Düzeyleri ve Meme Kanserine Yönelik Farkındalıkları. Uluslararası Hematoloji-Onkoloji Dergisi, Cilt: 25 - Sayı: 1, 60–69. https://ajindex.com/articles/323153

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Shrestha LB. Population aging in developing countries. Health Aff (Millwood) 19: 204-212, 2000.
  2. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin 56: 106-130, 2006.
  3. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin 58: 71-96, 2008.
  4. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009. CA Cancer J Clin 59: 225-249, 2009.
  5. Kimmick GG, Balducci L. Breast cancer and aging. Hematol Oncol Clin North Am 14: 213- 233, 2000.
  6. Edward NI, Jones DA. Uptake of breast cancer screening in older women. Age and Aging 29: 131-135, 2000. The Ministry of Health of Turkey. Health Statistics Yearbook 2010.
  7. Mollahaliloglu S, Basara BB, Eryilmaz Z (eds). Ankara, Kalkan Press, 2011: 25. Gross RE. Breast cancer: Risk factors, screening, and prevention. Semin Oncol Nurs 16: 176-84, 2000. Vogel VG. Breast cancer prevention: A review of current evidence. CA. Cancer J Clin 50: 156-170, 2000.
  8. Kimmick GG, Muss HB. Breast cancer in older patients. Semin Oncol 31: 234-248, 2004.
  9. Elverici E, Barça AN, Düzegün AP, et al. Breast Imaging Findings among the women patients in the geriatric age group. TJG 10: 1-4, 2007.
  10. Arslan Ç, Kilickap S, Dede DS, et al. Frequency of cancer types in patents aged 65 and older: results from cancer registry data base of Hacettepe University Hospitals. TJG 14: 187-192, 2011.
  11. Ozmen V, Ozcinar V, Karanlik H, et al. Breast cancer risk factors in Turkish women – a University Hospital based nested case control study. World J Surg Oncol 8: 37, 2009.
  12. Spence WR. Health EDCO. Inc, Waco, Texas, A Division of WRS Group, 2000. Champion VL. Instrument Development for Health Belief Model Constructs. Advance in Nursing Science 6: 73-85, 1984.
  13. Tümer A, Bayek H. Çalisan kadinlarda meme kanseri risk düzeyi. J Breast Health 6: 17-21, 2010.
  14. Eroglu C, Eryilmaz MA, Civcik S, Gurbuz Z. Breast Cancer Risk Assessment: 5000 Cases. UHOD 20: 27-33, 2010.
  15. Fisher B, Dignam J, Wolmark N, et al. Tamoxifen in treatment of intraductal breast cancer: National surgical adjuvant breast and bowel project B-24 randomized controlled trial. Lancet 353: 1993-2000, 1999.
  16. Martin AM, Weber BL. Genetic and hormonal risk factors in breast cancer. J Natl Cancer Inst 92: 1126- 1135, 2000. Collaborotive Group on Hormonal Factors in Breast Cancer Familial breast cancer. Collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease. Lancet 358: 1389-1399, 2001. Colditz